Literature DB >> 21493784

Histone acetylation regulates the cell-specific and interferon-γ-inducible expression of extracellular superoxide dismutase in human pulmonary arteries.

Igor N Zelko1, Marcus W Stepp, Alan L Vorst, Rodney J Folz.   

Abstract

Extracellular superoxide dismutase (EC-SOD) is the major antioxidant enzyme present in the vascular wall, and is responsible for both the protection of vessels from oxidative stress and for the modulation of vascular tone. Concentrations of EC-SOD in human pulmonary arteries are very high relative to other tissues, and the expression of EC-SOD appears highly restricted to smooth muscle. The molecular basis for this smooth muscle-specific expression of EC-SOD is not known. Here we assessed the role of epigenetic factors in regulating the cell-specific and IFN-γ-inducible expression of EC-SOD in human pulmonary artery cells. The analysis of CpG site methylation within the promoter and coding regions of the EC-SOD gene demonstrated higher levels of DNA methylation within the distal promoter region in endothelial cells compared with smooth muscle cells. Exposure of both cell types to DNA demethylation agents reactivated the transcription of EC-SOD in endothelial cells alone. However, exposure to the histone deacetylase inhibitor trichostatin A (TSA) significantly induced EC-SOD gene expression in both endothelial cells and smooth muscle cells. Concentrations of EC-SOD mRNA were also induced up to 45-fold by IFN-γ in smooth muscle cells, but not in endothelial cells. The IFN-γ-dependent expression of EC-SOD was regulated by the Janus tyrosine kinase/signal transducers and activators of transcription proteins signaling pathway. Simultaneous exposure to TSA and IFN-γ produced a synergistic effect on the induction of EC-SOD gene expression, but only in endothelial cells. These findings provide strong evidence that EC-SOD cell-specific and IFN-γ-inducible expression in pulmonary artery cells is regulated, to a major degree, by epigenetic mechanisms that include histone acetylation and DNA methylation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21493784      PMCID: PMC3262691          DOI: 10.1165/rcmb.2011-0012OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  40 in total

1.  Lung extracellular superoxide dismutase overexpression lessens bleomycin-induced pulmonary hypertension and vascular remodeling.

Authors:  Zachary Van Rheen; Cheryl Fattman; Shannon Domarski; Susan Majka; Dwight Klemm; Kurt R Stenmark; Eva Nozik-Grayck
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-10       Impact factor: 6.914

2.  Stimulation of primary human endothelial cell proliferation by IFN.

Authors:  Dolores Gomez; Nancy C Reich
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

3.  Increased superoxide anion release from human endothelial cells in response to cytokines.

Authors:  T Matsubara; M Ziff
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

4.  Myeloid zinc finger (MZF)-like, Kruppel-like and Ets families of transcription factors determine the cell-specific expression of mouse extracellular superoxide dismutase.

Authors:  Igor N Zelko; Rodney J Folz
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

5.  Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells.

Authors:  P Strålin; S L Marklund
Journal:  Atherosclerosis       Date:  2000-08       Impact factor: 5.162

6.  Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites.

Authors:  Stanislas Goriely; Dominique Demonté; Séverine Nizet; Dominique De Wit; Fabienne Willems; Michel Goldman; Carine Van Lint
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

7.  Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.

Authors:  Igor N Zelko; Rodney J Folz
Journal:  Free Radic Biol Med       Date:  2004-10-15       Impact factor: 7.376

8.  Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases.

Authors:  Tianshuang Liu; Shawn Castro; Allan R Brasier; Mohammad Jamaluddin; Roberto P Garofalo; Antonella Casola
Journal:  J Biol Chem       Date:  2003-10-24       Impact factor: 5.157

9.  Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro.

Authors:  G K Hansson; L Jonasson; J Holm; M M Clowes; A W Clowes
Journal:  Circ Res       Date:  1988-10       Impact factor: 17.367

10.  Binding of human extracellular-superoxide dismutase C to cultured cell lines and to blood cells.

Authors:  K Karlsson; S L Marklund
Journal:  Lab Invest       Date:  1989-05       Impact factor: 5.662

View more
  14 in total

Review 1.  Extracellular superoxide dismutase and its role in cancer.

Authors:  Brandon Griess; Eric Tom; Frederick Domann; Melissa Teoh-Fitzgerald
Journal:  Free Radic Biol Med       Date:  2017-08-24       Impact factor: 7.376

2.  Regulation of Oxidative Stress in Pulmonary Artery Endothelium. Modulation of Extracellular Superoxide Dismutase and NOX4 Expression Using Histone Deacetylase Class I Inhibitors.

Authors:  Igor N Zelko; Rodney J Folz
Journal:  Am J Respir Cell Mol Biol       Date:  2015-10       Impact factor: 6.914

3.  Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer.

Authors:  Bhupendra Singh; Hari K Bhat
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

4.  Akt2 (Protein Kinase B Beta) Stabilizes ATP7A, a Copper Transporter for Extracellular Superoxide Dismutase, in Vascular Smooth Muscle: Novel Mechanism to Limit Endothelial Dysfunction in Type 2 Diabetes Mellitus.

Authors:  Varadarajan Sudhahar; Mustafa Nazir Okur; Zsolt Bagi; John P O'Bryan; Nissim Hay; Ayako Makino; Vijay S Patel; Shane A Phillips; David Stepp; Masuko Ushio-Fukai; Tohru Fukai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-04       Impact factor: 8.311

5.  Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas.

Authors:  Brandon Griess; David Klinkebiel; Alice Kueh; Michelle Desler; Kenneth Cowan; Matthew Fitzgerald; Melissa Teoh-Fitzgerald
Journal:  Epigenetics       Date:  2020-06-14       Impact factor: 4.528

6.  Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.

Authors:  Eva Nozik-Grayck; Crystal Woods; Robert S Stearman; Sujatha Venkataraman; Bradley S Ferguson; Kalin Swain; Russell P Bowler; Mark W Geraci; Kaori Ihida-Stansbury; Kurt R Stenmark; Timothy A McKinsey; Frederick E Domann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-27       Impact factor: 5.464

7.  Exercise improves angiogenic function of circulating exosomes in type 2 diabetes: Role of exosomal SOD3.

Authors:  Kareem Abdelsaid; Varadarajan Sudhahar; Ryan A Harris; Archita Das; Seock-Won Youn; Yutao Liu; Maggie McMenamin; Yali Hou; David Fulton; Mark W Hamrick; Yaoliang Tang; Tohru Fukai; Masuko Ushio-Fukai
Journal:  FASEB J       Date:  2022-03       Impact factor: 5.834

Review 8.  Epigenetics and miRNA emerge as key regulators of smooth muscle cell phenotype and function.

Authors:  Rachel L Clifford; Cherie A Singer; Alison E John
Journal:  Pulm Pharmacol Ther       Date:  2012-07-16       Impact factor: 3.410

9.  Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension.

Authors:  Elaine Soon; Alexi Crosby; Mark Southwood; Peiran Yang; Tamara Tajsic; Mark Toshner; Sarah Appleby; Catherine M Shanahan; Kenneth D Bloch; Joanna Pepke-Zaba; Paul Upton; Nicholas W Morrell
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 30.528

10.  Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1.

Authors:  A Holownia; R M Mroz; P Wielgat; P Jakubow; J Jablonski; J Sulek; J J Braszko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-28       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.